N-[4-[(2-carbamoyl-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide
C26H23FN4O4 — CID 126617917
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[(2-carbamoyl-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide
N-[4-[(2-carbamoyl-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide (PubChem CID 126617917) has the molecular formula C26H23FN4O4 and a molecular weight of 474.49 g/mol. Its IUPAC name is N-[4-[(2-carbamoyl-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-[(2-carbamoyl-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide |
|---|---|
| PubChem CID | 126617917 |
| Molecular Formula | C26H23FN4O4 |
| Molecular Weight | 474.49 g/mol |
| Exact Mass | 474.17 |
| IUPAC Name | N-[4-[(2-carbamoyl-4-pyridinyl)oxy]-3-fluorophenyl]-6-ethyl-1,2-dimethyl-4-oxoquinoline-3-carboxamide |
| SMILES | CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(C(N)=O)c3)c(F)c1)c(C)n2C |
| InChI | InChI=1S/C26H23FN4O4/c1-4-15-5-7-21-18(11-15)24(32)23(14(2)31(21)3)26(34)30-16-6-8-22(19(27)12-16)35-17-9-10-29-20(13-17)25(28)33/h5-13H,4H2,1-3H3,(H2,28,33)(H,30,34) |
| InChIKey | XUGVMBPFSWNFIY-UHFFFAOYSA-N |
| XLogP | 4.09 |
| TPSA | 116.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 474.49 |
| LogP ≤ 5 | 4.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126617917 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.